Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Technip Energies (PARIS:TE) has been awarded two large(1) contracts by Bharat Petroleum Corporation Limited (BPCL) for key projects at its Bina refinery in Madhya Pradesh and Mumbai refinery in...
Read More -
Nikon has announced the NIKKOR Z 24–105mm f/4–7.1, a flexible all-purpose zoom for the Z system designed with portability and ease of use in mind NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) --...
Read More
-
DUBAI, The United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) -- B2BROKER, a global fintech solutions provider for financial institutions, unveiled its Fintech Market Report 2025. Drawing from...
-
LEI: 213800NNT42FFIZB1T09 07 January 2026 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce further progress across its greenfield platform, strengthening the value and maturity of its project portfolio. Following the...
-
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 January 2026 at 08.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act...
-
COMPANY ANNOUNCEMENT NO. 54-2025FLSmidth & Co. A/S7 January 2026Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (“FLSmidth”) initiated a share buy-back programme of up to DKK 1.4...
-
New York , Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vetted Prop Firms, a leading independent review and comparison platform for proprietary trading firms, has announced a new strategic partnership with...
-
Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
-
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...
-
LONDON, 07 Jan. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...